Archive for March 9th, 2011

Updates for NABI AEZS CORT ABIO and ZCLS

Mar 09, 2011 No Comments by

Nabi Biopharmaceuticals (Nasdaq:NABI) said yesterday that they expect final data in the first of the two NicVAX Phase III clinical trials for for the treatment of nicotine addiction in 2H 2011. Aeterna Zentaris Inc. (NASDAQ: AEZS) and Yakult Honsha Co., Ltd. announced the signing of a development, commercialization and licensing agreement for the development, registration […]

Daily News Read more